Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Trotter

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Journal of Neuroimmunology|May 1, 1997
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptidesJ L Trotter, C A Damico, A H Cross, et al.
The Journal of Infectious Diseases|November 1, 2019
Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic ResponseLaura V Cooper, Olivier Ronveaux, Katya Fernandez, et al.
Vaccine|January 27, 2018
Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from GhanaLaura V Cooper, James M Stuart, Charles Okot, et al.
NIHR Open Research|November 3, 2025
Mapping Community Vulnerability to reduced Vaccine Impact in Uganda and Kenya: A spatial Data-driven ApproachRobinah Nalwanga, Agnes Natukunda, Ludoviko Zirimenya, et al.
Vaccine|July 12, 2008
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeCaroline L Trotter, Jodie McVernon, Mary E Ramsay, et al.
The European Respiratory Journal|March 21, 2015
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumoniaChamira Rodrigo, Thomas Bewick, Carmen Sheppard, et al.
Communicable Disease and Public Health|November 19, 2002
Estimating the burden of serogroup C meningococcal disease in England and WalesK L Davison, M E Ramsay, N S Crowcroft, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptidesM K Kennedy, L J Tan, M C Dal Canto, et al.
Journal of Medical Microbiology|June 15, 2006
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference UnitStephen J Gray, Caroline L Trotter, Mary E Ramsay, et al.
The Lancet. Infectious Diseases|May 27, 2017
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance dataCaroline L Trotter, Clément Lingani, Katya Fernandez, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Journal of Neuroimmunology|May 1, 1997
HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid protein peptidesJ L Trotter, C A Damico, A H Cross, et al.
The Journal of Infectious Diseases|November 1, 2019
Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic ResponseLaura V Cooper, Olivier Ronveaux, Katya Fernandez, et al.
Vaccine|January 27, 2018
Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from GhanaLaura V Cooper, James M Stuart, Charles Okot, et al.
NIHR Open Research|November 3, 2025
Mapping Community Vulnerability to reduced Vaccine Impact in Uganda and Kenya: A spatial Data-driven ApproachRobinah Nalwanga, Agnes Natukunda, Ludoviko Zirimenya, et al.
Vaccine|July 12, 2008
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeCaroline L Trotter, Jodie McVernon, Mary E Ramsay, et al.
The European Respiratory Journal|March 21, 2015
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumoniaChamira Rodrigo, Thomas Bewick, Carmen Sheppard, et al.
Communicable Disease and Public Health|November 19, 2002
Estimating the burden of serogroup C meningococcal disease in England and WalesK L Davison, M E Ramsay, N S Crowcroft, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptidesM K Kennedy, L J Tan, M C Dal Canto, et al.
Journal of Medical Microbiology|June 15, 2006
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference UnitStephen J Gray, Caroline L Trotter, Mary E Ramsay, et al.
The Lancet. Infectious Diseases|May 27, 2017
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance dataCaroline L Trotter, Clément Lingani, Katya Fernandez, et al.
Pageof 16